Spearmon accepts three-month ban

American sprinter Wallace Spearmon has accepted a three-month suspension after testing positive for methylprednisolone, the United States Anti-Doping Agency has announced.

The 29-year-old 200 metres specialist returned a positive test in an in-competition urine sample collected at the Edmonton International Track Classic in July.

Methylprednisolone is a glucocorticosteroid prohibited in competition and classified as a specified substance, meaning its presence can come with a reduced sanction.